Registration Header

DCAT Sharp Sourcing: Global Thought Leaders in Pharma Sourcing and Supply Management

START DATE:1/26/2021




This 90-minute webinar brings together a panel of industry experts to offer valuable and practical insights into what companies need to consider and the options available to them for further fortifying their manufacturing and supply chains. This webinar will address whether a new normal in manufacturing and supply networks is required in wake of COVID-19, including increasing domestic manufacturing, and what considerations companies should factor in for supply assurance and risk mitigation.

Please note: This is a live presentation and no recording of the program will be offered.


Laurie J. Chipperfield

Senior Director, Global External Supply, Pfizer Worldwide Research & Development


Laurie J. Chipperfield is Senior Director, Global External Supply, Pfizer Worldwide Research & Development. She joined Pfizer Inc. in 1989 and has held positions of increasing leadership in the areas of operations, supply chain, regulatory, and strategic sourcing. She is currently Senior Director, Global External Supply, responsible for all externally sourced active pharmaceutical ingredients (APIs) and API intermediates manufactured for the company’s clinical portfolio. Prior to her current role, she had roles at Pfizer locations in Groton, Connecticut; New York, New York; and Puerto Rico and also supported Pfizer’s commercial manufacturing sites in Europe. She received a Bachelor of Science degree in chemical engineering from Northeastern University and an MBA from Rensselaer Polytechnic Institute.

Andrew D. Skibo

Chief Manufacturing Officer, FluGen, and Former Head of Global Biologics Operations


Andrew D. Skibo is Chief Manufacturing Officer, FluGen, a vaccine-development company, and former Head of Global Biologics Operations for AstraZeneca, from which he retired in 2019 and now serves an advisory/consultancy role to the company. He has over 40 years of experience in the pharmaceutical industry, with a career focused on manufacturing operations, quality, process development, and capital project development. Prior to retiring in April 2019, Mr. Skibo served for eleven years as MedImmune’s Executive Vice President of Operations and Astra Zeneca’s Head of Global Biologics Operations. The latter role included responsibilities for AstraZeneca’s biologics and vaccine franchises. He has related experience with both operating companies (Amgen, Roche’s Genentech, and Monsanto [now part of Bayer]) and large international engineering and construction firms specializing in the biopharmaceutical/pharmaceutical industry (Foster Wheeler, Life Sciences International, and Fluor). He has served as Chairman of the International Society of Pharmaceutical Engineering (ISPE) and Chairman of the Global Pharmaceutical Manufacturers Leadership Forum. He holds a Bachelor’s of Science degree in chemistry and a Master’s of Science degree in chemical engineering, both from the Massachusetts Institute of Technology.

Chad P. Bown, PhD

Senior Fellow

The Peterson Institute for International Economics

Chad P. Bown, PhD, is Senior Fellow, the Peterson Institute for International Economics (PIIE), where his research examines international trade laws and institutions, trade negotiations, and trade disputes. Prior to joining PIIE in 2018, Dr. Bown previously served as Senior Economist for International Trade and Investment in the White House on the Council of Economic Advisers, and most recently, as a lead economist at the World Bank, where he conducted research and advised developing country governments on international trade policy for seven years. Dr. Bown was a tenured professor of economics at Brandeis University, where he held a joint appointment in the Department of Economics and International Business School for 12 years. He has also spent a year in residence as a visiting scholar in economic research at the World Trade Organization (WTO) Secretariat in Geneva. Dr. Bown is also currently a research fellow at the Centre for Economic Policy Research in London and a member of the Council on Foreign Relations.

Jim Miller

Content Advisor/Consultant


Jim Miller is Content Advisor/Consultant to the Drug, Chemical & Associated Technologies Association (DCAT). He is a preeminent expert in bio/pharmaceutical outsourcing and industry consultant with more than 20 years of experience in the bio/pharmaceutical industry.
First Name
Last Name
Email Address
Job Title
Zip/Postal Code
Discount Code (If Applicable)